Clinically Mild Encephalopathy With a Reversible Splenial Lesion Type 2 Caused by Human Herpesvirus 6 Infection.


Journal

Pediatric neurology
ISSN: 1873-5150
Titre abrégé: Pediatr Neurol
Pays: United States
ID NLM: 8508183

Informations de publication

Date de publication:
12 2020
Historique:
received: 12 06 2020
revised: 24 08 2020
accepted: 28 08 2020
pubmed: 5 10 2020
medline: 9 10 2021
entrez: 4 10 2020
Statut: ppublish

Résumé

Clinically mild encephalopathy with a reversible splenial lesion (MERS) is the second commonest cause of encephalopathy. Several pathogens have been detected in patients with MERS type 2, such as influenza A and B, but little is known about the proportion of cases of MERS type 2 with this pathogenesis. Human herpesvirus 6 (HHV6) is the second commonest pathogen causing acute encephalopathy. However, HHV6 has not been previously reported in patients with MERS type 2. In this report, we describe a five-year-old boy with MERS type 2 caused by HHV6 infection. The present case was diagnosed with MERS type 2 caused by HHV6 infection based on the characteristic clinical course, the results of the virus testing, and imaging findings. This is the first description of MERS type 2 caused by HHV6 infection. Although there is a report of MERS type 1 caused by HHV6 infection, there are no detailed reports in the literature about MERS type 2 associated with HHV6 infection. Thus the clinical findings associated with MERS type 2 caused by HHV6 infection are poorly understood. This report indicates that HHV6 can cause MERS type 2.

Sections du résumé

BACKGROUND
Clinically mild encephalopathy with a reversible splenial lesion (MERS) is the second commonest cause of encephalopathy. Several pathogens have been detected in patients with MERS type 2, such as influenza A and B, but little is known about the proportion of cases of MERS type 2 with this pathogenesis. Human herpesvirus 6 (HHV6) is the second commonest pathogen causing acute encephalopathy. However, HHV6 has not been previously reported in patients with MERS type 2.
PATIENT DESCRIPTION
In this report, we describe a five-year-old boy with MERS type 2 caused by HHV6 infection. The present case was diagnosed with MERS type 2 caused by HHV6 infection based on the characteristic clinical course, the results of the virus testing, and imaging findings.
DISCUSSION
This is the first description of MERS type 2 caused by HHV6 infection. Although there is a report of MERS type 1 caused by HHV6 infection, there are no detailed reports in the literature about MERS type 2 associated with HHV6 infection. Thus the clinical findings associated with MERS type 2 caused by HHV6 infection are poorly understood. This report indicates that HHV6 can cause MERS type 2.

Identifiants

pubmed: 33011640
pii: S0887-8994(20)30304-0
doi: 10.1016/j.pediatrneurol.2020.08.021
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

43-45

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Fumikazu Sano (F)

Faculty of Medicine, Department of Pediatrics, University of Yamanashi, Yamanashi, Japan. Electronic address: fsano@yamanashi.ac.jp.

Toshimichi Fukao (T)

Faculty of Medicine, Department of Pediatrics, University of Yamanashi, Yamanashi, Japan.

Kei Tamaru (K)

Faculty of Medicine, Department of Pediatrics, University of Yamanashi, Yamanashi, Japan.

Hideaki Kanemura (H)

Faculty of Medicine, Department of Pediatrics, University of Yamanashi, Yamanashi, Japan; Department of Pediatrics, Toho University Medical Center Sakura Hospital, Chiba, Japan.

Takeshi Inukai (T)

Faculty of Medicine, Department of Pediatrics, University of Yamanashi, Yamanashi, Japan.

Masao Aihara (M)

Faculty of Medicine, Department of Pediatrics, University of Yamanashi, Yamanashi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH